Cargando…

Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series

SIMPLE SUMMARY: The management of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis (NF2) is complex. Current treatment strategies include active surveillance, surgery, radiotherapy, and pharmacotherapy. Due to treatment side effects such as hearing loss, balance complaints,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douwes, Jules P. J., Koetsier, Kimberley S., van Dam, Victor S., Plotkin, Scott R., Barker, Frederick G., Welling, D. Bradley, Jansen, Jeroen C., Hensen, Erik F., Shih, Helen A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047060/ https://www.ncbi.nlm.nih.gov/pubmed/36975476 http://dx.doi.org/10.3390/curroncol30030263

Ejemplares similares

Vestibular dysfunction in NF2–related schwannomatosis
por: Madhani, Amsal S, et al.
Publicado: (2023)

Labyrinthine Fluid Signal Intensity on T2-Weighted MR Imaging in Patients With Vestibular Schwannomas Undergoing Proton Radiotherapy: A Longitudinal Assessment
por: Koetsier, Kimberley S., et al.
Publicado: (2023)

The comparable tumour microenvironment in sporadic and NF2-related schwannomatosis vestibular schwannoma
por: Gregory, Grace E, et al.
Publicado: (2023)

A systematic review of targeted therapy for vestibular schwannoma in patients with NF2-related schwannomatosis
por: Chiranth, Shivani, et al.
Publicado: (2023)

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma
por: Plotkin, Scott R, et al.
Publicado: (2023)

Correction to: Vestibular dysfunction in NF2–related schwannomatosis
Publicado: (2023)

Cochlear-optimized treatment planning in photon and proton radiosurgery for vestibular schwannoma patients
por: Koetsier, Kimberley S., et al.
Publicado: (2023)

Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients
por: Webb, M J, et al.
Publicado: (2023)

Left atrial schwannoma in schwannomatosis: a case report
por: Yokoyama, Kenji, et al.
Publicado: (2021)

Vestibular Complaints Impact on the Long-Term Quality of Life of Vestibular Schwannoma Patients
por: Fuentealba-Bassaletti, Constanza, et al.
Publicado: (2023)

Prognostic Factors for the Outcome of Translabyrinthine Surgery for Vestibular Schwannomas
por: de Boer, Nick P., et al.
Publicado: (2021)

New developments in neurofibromatosis type 2 and vestibular schwannoma
por: Ren, Yin, et al.
Publicado: (2020)

Laminectomy triggers symptomatic growth of spinal schwannoma in a patient with schwannomatosis
por: Oyama, Takahiro, et al.
Publicado: (2022)

The impact of vestibular schwannoma and its management on employment
por: Neve, O. M., et al.
Publicado: (2021)

Vestibular schwannoma surgery
por: Link, Michael J., et al.
Publicado: (2021)

Identification of Immune-Related Candidate Biomarkers in Plasma of Patients with Sporadic Vestibular Schwannoma: Candidate Plasma Biomarkers in Vestibular Schwannoma
por: Vasilijic, Sasa, et al.
Publicado: (2023)

Cochlear Implantation After Radiotherapy of Vestibular Schwannomas
por: Tian, Luchen, et al.
Publicado: (2021)

Multiple Schwannomas of the Spine: Review of the Schwannomatosis or Congenital Neurilemmomatosis: A Case Report
por: Lee, Sang-Hoon, et al.
Publicado: (2015)

Intraosseous schwannoma of the mandible and schwannoma of the spinal cord: A rare presentation of schwannomatosis – Case report and review of the literature
por: Vasudevan, Remesh, et al.
Publicado: (2019)

Therapy of Sporadic and NF2-Related Vestibular Schwannoma
por: Yao, Longping, et al.
Publicado: (2020)

A resected case of schwannomatosis involving an extremely rare phrenic neurogenic plexiform schwannoma
por: Tsuchida, Hiroyuki, et al.
Publicado: (2023)

Pain correlates with germline mutation in schwannomatosis
por: Jordan, Justin T., et al.
Publicado: (2018)

Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
por: Sagers, Jessica E., et al.
Publicado: (2018)

A prediction model for recurrence after translabyrinthine surgery for vestibular schwannoma: toward personalized postoperative surveillance
por: de Boer, Nick P., et al.
Publicado: (2022)

WP1066 induces cell death in a schwannomatosis patient–derived schwannoma cell line
por: Allaf, Abdulrahman, et al.
Publicado: (2022)

Epigenomic, genomic, and transcriptomic landscape of schwannomatosis
por: Mansouri, Sheila, et al.
Publicado: (2020)

Metachronous schwannoma in the colon with vestibular schwannoma
por: Jung, Eun-Joo, et al.
Publicado: (2014)

The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis
por: Gregory, Grace E, et al.
Publicado: (2023)

Polyradiculopathies from Schwannomatosis
por: Jia, Yuxia, et al.
Publicado: (2011)

Genetic and Epigenetic Alterations of the NF2 Gene in Sporadic Vestibular Schwannomas
por: Lee, Jong Dae, et al.
Publicado: (2012)

Multiple Unilateral Vestibular Schwannomas: Segmental NF2 or Sporadic Occurrence?
por: Carlson, Matthew L., et al.
Publicado: (2016)

Management of neurofibromatosis type 2 and schwannomatosis associated peripheral and intraspinal schwannomas: influence of surgery, genetics, and localization
por: Gugel, Isabel, et al.
Publicado: (2022)

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
por: Banerjee, Jineta, et al.
Publicado: (2023)

Sulforaphane, a natural component of broccoli, inhibits vestibular schwannoma growth in vitro and in vivo
por: Kim, Bo Gyung, et al.
Publicado: (2016)

Publisher Correction: Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
por: Sagers, Jessica E., et al.
Publicado: (2018)

Vestibular Migraine Following Radiosurgery for Vestibular Schwannoma
por: Chae, Ricky, et al.
Publicado: (2020)

Electrical Vestibular Stimulation after Vestibular Deafferentation and in Vestibular Schwannoma
por: Aw, Swee Tin, et al.
Publicado: (2013)

Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis
por: Bachir, Suha, et al.
Publicado: (2021)

Translabyrinthine resection of NF2 associated vestibular schwannoma with cochlear implant insertion
por: Hannan, Cathal John, et al.
Publicado: (2021)

Identification of immune-related candidate biomarkers in plasma of patients with sporadic vestibular schwannoma
por: Vasilijic, Sasa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5fnb9pgfk5id1a7s5m9kdn6b78